For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Melatonin1+3 | Melatonin: 1 or 3 mg of melatonin PO each night for 12 months | None | None | 5 | 40 | 19 | 40 | View |
| Placebo | Identical placebo given nightly for 12 months | None | None | 7 | 41 | 17 | 41 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Planned operation | None | Musculoskeletal and connective tissue disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Infection not assumed related to study medicine | None | Infections and infestations | None | View |